BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6155058)

  • 21. [Variations of cerebral biogenic amines after injection of 4-butyrolactone].
    Nouaille-Degorce J; Riotte M; Barras B; Pegon Y; Cier A
    C R Seances Soc Biol Fil; 1971; 165(7):1676-81. PubMed ID: 4261929
    [No Abstract]   [Full Text] [Related]  

  • 22. Selectivity of pentylenetetrazol on brain monoamine metabolism.
    McMillen B; Isaac L
    Biochem Pharmacol; 1974 Apr; 23(7):1223-5. PubMed ID: 4823456
    [No Abstract]   [Full Text] [Related]  

  • 23. Depressive Behavior and Monoamine Contents in Brain Structures of Rats During Chronic Overcrowding.
    Loseva EV; Sarkisova KY; Loginova NA; Kudrin VS
    Bull Exp Biol Med; 2015 Jul; 159(3):327-30. PubMed ID: 26212807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Catecholamine and indoleamine metabolism in groups of patients with paranoid and simple forms of schizophrenia].
    Gamaleia NB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(5):700-8. PubMed ID: 6168149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic treatment with haloperidol or fluphenazine decanoate: regional effects on dopamine and serotonin metabolism in primate brain.
    Bacopoulos NG; Bustos G; Redmond DE; Roth RH
    J Pharmacol Exp Ther; 1982 Apr; 221(1):22-8. PubMed ID: 6174729
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of chronically administered L-dopa in normal and lesioned cats.
    Langelier P; Roberge AG; Boucher R; Poirier LJ
    J Pharmacol Exp Ther; 1973 Oct; 187(1):15-26. PubMed ID: 4746324
    [No Abstract]   [Full Text] [Related]  

  • 27. Brain monoamines in the rhesus monkey during long-term neuroleptic administration.
    Shannak KS; Hornykiewicz O
    Adv Biochem Psychopharmacol; 1980; 24():315-23. PubMed ID: 6157310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baclofen and gamma-hydroxybutyrate: similar effects on cerebral dopamine neurones.
    Da Prada M; Keller HH
    Life Sci; 1976 Oct; 19(8):1253-63. PubMed ID: 994724
    [No Abstract]   [Full Text] [Related]  

  • 29. Neurotransmitters in the brains of patients with dementia disorders.
    Gottfries CG
    Dan Med Bull; 1985 Feb; 32 Suppl 1():44-8. PubMed ID: 2580668
    [No Abstract]   [Full Text] [Related]  

  • 30. Biochemical neuropathology of Parkinson's disease.
    Javoy-Agid F; Ruberg M; Taquet H; Bokobza B; Agid Y; Gaspar P; Berger B; N'Guyen-Legros J; Alvarez C; Gray F
    Adv Neurol; 1984; 40():189-98. PubMed ID: 6695594
    [No Abstract]   [Full Text] [Related]  

  • 31. Some neuropharmacological effects of Ro 11-2465--a novel tricyclic antidepressant with potent inhibitory activity on the uptake of 5-HT.
    Da Prada M; Keller HH; Burkard WP; Schaffner R; Bonetti EP; Launay JM; Haefely W
    Adv Biochem Psychopharmacol; 1982; 31():235-48. PubMed ID: 6177199
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of theophylline on monoamine metabolism in the rat brain.
    Karasawa T; Furukawa K; Yoshida K; Shimizu M
    Eur J Pharmacol; 1976 May; 37(1):97-104. PubMed ID: 776632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dopamine hypothesis in schizophrenia--recent findings in limbic system abnormality].
    Toru M; Watanabe S; Kaneno S
    Nihon Rinsho; 1978; 36(1):76-82. PubMed ID: 24768
    [No Abstract]   [Full Text] [Related]  

  • 34. Neurotransmitters, precursors and metabolites in spinal cord and brain of Lewis rats with EAE.
    Honegger CG; Isler H
    Prog Clin Biol Res; 1984; 146():131-8. PubMed ID: 6201886
    [No Abstract]   [Full Text] [Related]  

  • 35. [Amines in mental disorders (author's transl)].
    Takahashi R
    Tanpakushitsu Kakusan Koso; 1977; 22(6):815-21. PubMed ID: 337391
    [No Abstract]   [Full Text] [Related]  

  • 36. [Changes in metabolism of catecholamines and serotonin during alcohol withdrawal].
    Uchimura N; Nakamura J
    Nihon Rinsho; 1997 Feb; 55 Suppl():488-93. PubMed ID: 9078777
    [No Abstract]   [Full Text] [Related]  

  • 37. [Biogenic amines and their metabolites in brain tumor tissue].
    Kmieciak-Kołada K; Majchrzak H; Herman Z; Wencel T
    Neurol Neurochir Pol; 1984; 18(5):441-4. PubMed ID: 6084819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biochemical bases of Parkinson disease].
    Colucci d'Amato C; Puccini A; Cristillo A; Vizioli R
    Recenti Prog Med; 1984 Oct; 75(10):889-901. PubMed ID: 6151219
    [No Abstract]   [Full Text] [Related]  

  • 39. [Schizophrenia and cerebral amines].
    Véron JP; Kezirian S
    Presse Med (1893); 1971 Oct; 79(44):1973-4. PubMed ID: 5119550
    [No Abstract]   [Full Text] [Related]  

  • 40. Brain concentrations of biogenic amines and their metabolites in two types of pyrogen-induced fever in rabbits.
    Gardey-Levassort C; Tanguy O; Lechat P
    J Neurochem; 1977 Jan; 28(1):177-82. PubMed ID: 13153
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.